【生死教育第三講】
講題 Title:預設醫療指示與預設照顧計劃 Advance Directive and Advance Care Planning
報名鏈接Registration Link: https://bit.ly/3tE9RgE
日期 Date:12/6/2021(Sat)
時間 Time:3:00-4:30pm
地點 Venue:沙田澤祥街12號香港中文大學鄭裕彤樓地下演講廳1A (LT1A)
Lecture Theatre 1A, Level 1, Cheng Yu Tung Building, The Chinese University of Hong Kong, 12 Chak Cheung Street, Shatin, N.T.
講者 Speaker:陳裕麗教授 Prof Helen Chan / 鍾一諾教授 Prof Roger Chung
主持 Moderator:伍桂麟先生 Mr Pasu Ng
講座內容 Synopsis:
現今醫療科技發達,很多疾病均可治癒或受控制。當疾病到了末期,醫療科技有時只能提供維持生命治療,但延長死亡過程對病人可能沒有意義,甚至增加痛楚。面對這情況,病人、家屬和醫護人員可以商討是否中止對生活質素沒有幫助的維持生命治療,讓病人安詳離世。香港中文大學醫學院那打素護理學院副教授陳裕麗博士和香港中文大學公共衛生及基層醫療學院助理教授鍾一諾博士會在由中大公共衞生及基層醫療學院主辦的公眾「生死教育」四講系列的第三講和大家分享『預設醫療指示』 (Advance Directive)和『預設照顧計劃』(Advance Care Planning)的概念與應用。這兩種健康護理選擇不但可以免卻家屬決定病者死時所受到的困難和壓力,減少作出決定後感到矛盾和內疚的機會,亦體現對病者生命和意願的尊重。
Thanks to the advancement of medical technology, most diseases can be cured or subsided. However, there are times that medical technology could only prolong one’s life but could not cure the terminal illness. Facing such situation, patients, family members, and medical staff can discuss whether to withhold or withdraw from life-sustaining treatments that may not help improve patients’ quality of life so that they can die peacefully. Professor Helen Chan, Associate Professor from The Nethersole School of Nursing and Professor Roger Chung, Assistant Professor of the School of Public Health and Primary Care of the Chinese University of Hong Kong, will share with us the concepts and values behind Advance Directive and Advance Care Planning in the third public seminar of the four-lecture series on life and death education organized by the School of Public Health and Primary Care, CUHK. These two health care options aim not only to reduce the pressure faced by patients’ family when making end-of-life healthcare decision, but also show respect to patients’ will.
講者介紹:
Professor Helen Chan’s research interests focus on end-of-life care, gerontology as well as care ethics. She has conducted a number of research projects on promoting palliative and end-of-life care, especially advance care planning, among older adults and people with advanced progressive diseases.
陳裕麗教授的主要研究範疇集中在臨終護理、老年病學和護理倫理學上。她的研究項目包括推廣有關老人和晚期疾病患者的紓緩照顧和臨終護理服務,尤其是預設照顧計劃。
Professor Roger Chung’s research aims to empirically inquire into the social determinants of health inequalities, as well as aging‐related issues on multimorbidity and long‐term/end‐of‐life care, and to utilize such evidence to inform health services and policy, domestically and beyond.
鍾一諾教授的主要研究範疇為健康不平等的社會決定因素,與老年有關的多重疾病,和晚期與臨終護理政策,並運用研究成果為本地及國際公共衛生服務和政策提供意見。
生死教育 X 伍桂麟
research ethics 在 許藍方博士 Dr. Gracie Facebook 的最讚貼文
#drgracieofficial
《must-see film》Three identical strangers
#必看電影_netflex_threeidenticalstrangers
The film describes a true story about identical triplets becoming separated at birth and adopted by three families with different level.
Their amazing reunion became a global sensation when they’re adults. As the details unearthed, the crazy coincidence was the result of much darker events, which have major consequences for the triplets' lives.
However, the film delves into the conflict between science and ethics, and it also conveys the importance of empathy and sensitivity to others' needs.
Although the results of the unethical research are yet to be published, an obvious fact was shown from the film that a trait of a person is influenced by nature and nurture interaction.
有時候你會希望那是夢,而你也清楚知道那個夢境不可能被改變,而你那時唯一能做的就是接受,然後等待接下來會發生的事⋯from amazing to incredible.
When three separate lives become one, where’s the story eventually going?
G. Hsu
#在新的地方感受新鮮的氧氣為心靈沈澱
research ethics 在 台灣光鹽生物科技學苑 Facebook 的精選貼文
【International Live Webinar Series】Strategies for Applying Clinical Trials in Europe歐洲臨床試驗申請策略與佈局
🌍此次學苑特別推出國際線上同步遠距課程,並與德國講師合作,提供學員最新的國際臨床試驗實務課程!
此次課程為系列課程,首堂為”歐洲臨床試驗申請策略與佈局”。對於想往歐洲發展、合作或與歐洲從事臨床試驗的相關公司廠商有很大的幫助!
Date:
Part 1: 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
Part 2: 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
Location:Online Webinar Training
Instructor:Anika Staack, Founder of ARC-TRAICOA / EU-QPPV
【Course Outline】
Part 1 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
A. Europe – One Union with differences
B. European Clinical Trial Directive
1.Role of national competent authorities
2.Role of ethics committees (central / local)
3.Role of investigator
4.Role of sponsor
5.Role of EMA
C. Planning clinical trials in Europe
1.Analysis of product
a.Indication
b.Patient group
2.Analysis of end points
3 .Analysis of protocol
4.Preparing feasibility
5.Choosing Key Opinion Leaders
6.Sponsor or IIT?
7.Similar studies already running?
Part 2 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
A. Applying clinical trial
1.Collecting information you need
2.Establishing study team
B. Required entry into EudraCT
C. Required approval from national HAs and ethics
D. Required fulfilment of national data protection laws
E. Considerations
1.Doing it by yourselves
2.Contracting CRO
3.Auditing
F. Upcoming issues: Site and patient recruitment, site resources, patients withdrawal, protocol amendments
G. Final presentation of study reports
Online Course Fees include 2 Webinars, 90 minutes each:
Special Price $160 USD per Person; Original Price $180 USD
(*1) Certificate of Attendance will be issued only if participants attend both part 1 & 2 webinar
(*2) Certificate of Completed Assessment will be issued only if participant pass the assessment
Register here 👉 https://forms.gle/Kj9yMVynsq7yzSzs8
Organizer:ARC-TRAICOA
Co-Organizer:Salt and Light Institute
【Target Audience】
(1.) Anyone who is interested in clinical trials in Europe
(2.) Anyone who has experience in working in clinical trials related field such as PI,PM,RA,RD,MA,DM,ST,CRA, CRC,QC,QA, etc)
【Instructor CV】
Anika Staack
Current Position:
Founder of ARC-TRAICOA
EU-Qualified Person for Pharmacovigilance (EU-QPPV)
Local German QPPV Consultant and Speaker
Previous Experience:
EU-QPPV / Stufenplanbeauftragte & Group Leader PV at Medice
Senior Drug Safety Manager at ICON
Lead Site Management Associate at PRA
Clinical Research Associate at SKM Oncology
Expertise:
Expertise Databases: European Medicine Agency EudraVigilance and xEVMPD
Quality Assurance: Audits & Inspections, SOP Writing and QA documentation, recalls and product quality
Clinical Trial Management: Feasibility, monitoring, eCRF set-up, database reconciliation, site selection, contract management, patient recruitment, study reports
Authorization process: PSMF, RMP & PSUR Writing, answering authority requests, Risk Management, overseeing product life-cycle
Education Background:
Master of Science (Biology)
Email: bioschool@biotech-edu.com Tel: (+886) 02-2545-9721 ext.18
research ethics 在 Mandatory Student - 臺灣學術倫理教育資源中心 的相關結果
Republishing shall indicate the resource: Center for Taiwan Academic Research Ethics Education. Website: https://ethics.moe.edu.tw. ... <看更多>
research ethics 在 Ethics in Research - Research Methods 的相關結果
What is Research Ethics? · Honesty: Honestly report data, results, methods and procedures, and publication status. · Objectivity: · Integrity:. ... <看更多>
research ethics 在 What Is Ethics in Research & Why Is It Important? 的相關結果
When conducting research on human subjects, minimize harms and risks and maximize benefits; respect human dignity, privacy, and autonomy; take special ... ... <看更多>